Biodefense Headlines – November 2, 2014

Troops to be checked for chemical exposure in Iraq | Aerosolized fungal infection from bats | Recommendations regarding Ebola response | EVD-68 cases fading, but more unexplained neuro illnesses | Evaluation of border entry screening for infectious diseases in humans | FDA approves vaccine for a rare meningitis | Ebola: Failures of imagination | The decision to publish an avian H7N1 gain-of-function experiment | Novel biosensor could allow rapid detection of Ebola virus | BARDA: The venture capital firm buried in the U.S. government | Drug that lost high-stakes political fight for funding now being used against Ebola | Better staffing seen as crucial to Ebola treatment in Africa | Light frequencies help sniff out deadly materials from a distance | Ebola genome browser now online to aid researchers | The bad, the worse and the over-interpreted | CSL-Novartis deal includes US cell-based flu vaccine plant | Joint Chiefs chairman urges 21-day quarantine for troops in Ebola zone | “Airborne” Ebola: A review of the issue | Mandatory Ebola quarantine is about politics, not public health | WHO updates Ebola PPE guidance for health providers | Army providing communications backbone for Ebola response

See what we’re reading this week at Global Biodefense on EVD-68, DoD communication networks for Ebola crisis regions, new meningitis vaccine and more…

Troops to be checked for chemical exposure in Iraq (NY Times)

Aerosolized fungal infection from bats (GMU Pandora Report)

EVD-68 cases fading, but more unexplained neuro illnesses (CIDRAP)

Evaluation of border entry screening for infectious diseases in humans (EID Journal)

FDA approves vaccine for a rare meningitis (NY Times)

Ebola: Failures of imagination (Lanard and Sandman)

The decision to publish an avian H7N1 gain-of-function experiment (mBio)

Novel biosensor could allow rapid detection of Ebola virus (UC Santa Cruz)

BARDA: The venture capital firm buried in the U.S. government (Marketplace)

Drug that lost high-stakes political fight for funding now being used against Ebola (HP)

Better staffing seen as crucial to Ebola treatment in Africa (NY Times)

Light frequencies help sniff out deadly materials from a distance (HSNW)

Ebola genome browser now online to aid researchers (HealthCanal)

The bad, the worse and the over-interpreted (Virology Down Under)

CSL-Novartis deal includes US cell-based flu vaccine plant (CIDRAP)

Joint Chiefs chairman urges 21-day quarantine for troops in Ebola zone (NY Times)

Mandatory Ebola quarantine is about politics, not public health (The Conversation)

WHO updates Ebola PPE guidance for health providers (CIDRAP)

Army providing communications backbone for Ebola response (Defense Systems)

Ebola Virus

New Study Helping to Rewrite Ebola’s Family History

DoD Seeks Help Manufacturing Ebola EZ1 Assays